Nationwide Assessment of Robotic Lobectomy for Non-Small Cell Lung Cancer

Abstract

Robotic lobectomies have significantly increased in stage I to IIIA NSCLC patients, with outcomes similar to other approaches. Additional studies are needed to determine if this technology offers potential advantages compared with video-assisted thoracoscopic operations.

Hospital cost and clinical effectiveness of robotic-assisted versus video-assisted thoracoscopic and open lobectomy: A propensity score–weighted comparison

“…In the most recent nationwide report of lobectomy for lung cancer from the National Cancer Database, the majority of lobectomies, up to year 2012, were performed via thoracotomy. 1 Adoption of minimally invasive lobectomy by video-assisted thoracoscopic surgery (VATS) has been gradually increasing and more recently propelled after the introduction robotic-assisted thoracoscopic (robotic) lobectomy. 2 With multiple established techniques, and little existing randomized data, controversy remains about the best approach.…”

Measuring the quality of multi-disciplinary thoracic oncology care

“…Some initial attempts to measure these interactions have demonstrated potentially meaningful gaps in quality. Rajaram and colleagues found significant underutilization of adjuvant chemotherapy following surgical resection in a national study (12). Credentialing groups such as the Commission on Cancer have incorporated quality measures into the review paradigm for programs, but the areas that perform most poorly related to the transition of care from one specialist to another (13).…”

Robotic-assisted thoracoscopic surgery: state of the art and future perspectives

“…An analysis of the U.S. National Cancer Data Base showed that the percentage of robotic lobectomies increased from 3% in 2010 up to 9% in 2012 (8). A more recent market analysis that has been conducted in the U.S. by the end of 2015, showed that already around 15% of lobectomies were performed by RATS.…”